Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention?
An overview on aspirin-free strategies

Which future for aspirin in acute coronary syndromes treated with percutaneous coronary intervention? An overview on aspirin-free strategies

Bibliographic Details
Main Authors:	Luigi Spadafora, Marco Bernardi, Mattia Galli, Giuseppe Biondi-Zoccai, Pierre Sabouret
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-11-01
Series:	Archives of Medical Science
Online Access:	https://www.archivesofmedicalscience.com/Which-future-for-aspirin-in-acute-coronary-syndromes-treated-with-percutaneous-coronary,155411,0,2.html

Similar Items

Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?
by: Marco Bernardi, et al.
Published: (2023-02-01)

Aspirin Desensitization and Percutaneous Coronary Intervention in a Patient with Aspirin Hypersensitivity and Acute Coronary Syndrome: A Case Report
by: Suman Acharya, et al.
Published: (2024-06-01)

Coronary artery disease and transcatheter aortic valve implantation: diagnostic evaluation, management and indication for percutaneous revascularization
by: Dario Mafrica, et al.
Published: (2023-12-01)

Chronic coronary syndromes: diagnosis, management and gaps in evidence
by: Dario Mafrica, et al.
Published: (2024-08-01)

Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity
by: Konstantin A. Krychtiuk, MD, PhD, et al.
Published: (2024-11-01)

Aspirin Hypersensitivity in Patients with Coronary Artery Disease: An Updated Review and Practical Recommendations
by: Luigi Cappannoli, et al.
Published: (2024-10-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01)

To be or not to be on: aspirin and coronary artery bypass graft surgery
by: Aashray K. Gupta, et al.
Published: (2024-08-01)

EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY
by: A. M. Chernyavsky, et al.
Published: (2017-10-01)

Aspirin‐Free Strategy for Percutaneous Coronary Intervention in Patients With Oral Anticoagulation: Prespecified Subgroup Analysis From the STOPDAPT‐3 Trial
by: Masahiro Natsuaki, et al.
Published: (2024-08-01)

Aspirin-free P2Y12 inhibitor monotherapy immediately after percutaneous coronary intervention: A systematic review
by: Shenglong Yu, et al.
Published: (2024-08-01)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
by: Laura M. Willemsen, et al.
Published: (2021-12-01)

When early discharge after percutaneous coronary intervention is much too early
by: Zbigniew Siudak, et al.
Published: (2022-12-01)

Aspirin resistance in patients with acute coronary syndrome. Part 2
by: N. S. Frolova, et al.
Published: (2011-04-01)

Aspirin resistance in patients with acute coronary syndrome. Part 1
by: N. S. Frolova, et al.
Published: (2010-12-01)

The association between aspirin resistance and extent and severity of coronary atherosclerosis
by: Serkan Kahraman, et al.
Published: (2018-12-01)

The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention
by: Wen-Bo Dai, et al.
Published: (2024-12-01)

Real-world performance of indobufen versus aspirin after percutaneous coronary intervention: insights from the ASPIRATION registry
by: Chunfeng Dai, et al.
Published: (2024-04-01)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
by: Mesana Thierry G, et al.
Published: (2005-10-01)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
by: Shalin Rawal, et al.
Published: (2022-06-01)

An overview of the British and American aspirin studies.
by: Hennekens, C, et al.
Published: (1988)

Aspirin in the chemoprevention of colorectal neoplasia: an overview.
by: Chan, A, et al.
Published: (2012)

Critical Overview on the Benefits and Harms of Aspirin
by: Chun Shing Kwok, et al.
Published: (2010-05-01)

Out-of-hospital cardiac arrest: predict and then protect!
by: Luigi Spadafora, et al.
Published: (2023-04-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

Indirect comparison meta-analysis of aspirin therapy after coronary surgery.
by: Lim, E, et al.
Published: (2003)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
by: Qiu-Ping Shi, et al.
Published: (2022-08-01)

Cost-effectiveness and budget impact analysis of rivaroxaban with or without aspirin compared to aspirin alone in patients with coronary and peripheral artery diseases in Iran
by: Zahra Goudarzi, et al.
Published: (2025-03-01)

Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
by: Sanne Bøjet Larsen, et al.
Published: (2015-01-01)

Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review
by: Carol Gravinese, et al.
Published: (2017-08-01)

Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials
by: Debasu Z, et al.
Published: (2022-09-01)

Percutaneous coronary intervention in coronary total occlusions: In which patients?
by: Mario Araya, et al.
Published: (2016-07-01)

Role of nutrition and healthy lifestyle, for individuals in primary prevention: recent data, gaps in evidence and future directions
by: Theodora Metsovitis, et al.
Published: (2024-04-01)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
by: Yixi Zhao, et al.
Published: (2021-12-01)

Early in-hospital discontinuation of aspirin on the first post-procedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation
by: Philipp von Stein, et al.
Published: (2023-12-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease
by: Khomaziuk T.A., et al.
Published: (2013-10-01)

Impact of aspirin dosage on prognosis and coronary artery complications in pediatric Kawasaki disease patients
by: Liuyan Pan, et al.
Published: (2024-11-01)